2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$9.09+$0.09 (+1.00%)
Price as of Jun 23, 2026 4:46 PM EDT- $1.5BMarket Cap
- 42.63%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$9.09+$0.09 (+1.00%)
NVAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.00 | ||
Change | -$0.13 (-1.42%) | ||
Open | $9.16 | ||
High | $9.37 | ||
Low | $8.96 | ||
Previous Close | $9.13 | ||
Volume | 3,706,432 | ||
30-Day Average Volume | 5,290,020 | ||
1-Week Change | -2.28% | ||
1-Month Change | -2.28% | ||
1-Year Change | 42.63% | ||
3-Year Change | 25.70% | ||
5-Year Change | -95.37% | ||
Fundamentals | |||
Shares Outstanding | 164.4M | ||
Total Assets | $1.0B | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $42.2M | ||
Net Income | -$9.5M | ||
Free Cash Flow | -$33.7M | ||
EBIT | -$4.8M | ||
EBITDA | -$1.7M | ||
Net Working Capital | $508.4M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -906 | ||
Enterprise Value/Revenue | 37 | ||
P/B | -10 | ||
P/E | -150 | ||
PEG | 1 | ||
Price/Free Cash Flow | -44 | ||
Price/Operating Cash Flow | -46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/13/2007 | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 05/10/2019 | ||
Earnings & Revenue